CLCA2, a target of the p53 family, negatively regulates cancer cell migration and invasion.
about
Ion Channels in Brain MetastasisThe Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.CLCA2 as a novel immunohistochemical marker for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the lung.Secreted CLCA1 modulates TMEM16A to activate Ca(2+)-dependent chloride currents in human cells.A pseudogene-signature in glioma predicts survival.CLCA2 Interactor EVA1 Is Required for Mammary Epithelial Cell Differentiation.MALDI imaging reveals NCOA7 as a potential biomarker in oral squamous cell carcinoma arising from oral submucous fibrosis.ΔNp63α expression induces loss of cell adhesion in triple-negative breast cancer cells.Tyr99 phosphorylation determines the regulatory milieu of tumor suppressor p73.Mahanine synergistically enhances cytotoxicity of 5-fluorouracil through ROS-mediated activation of PTEN and p53/p73 in colon carcinoma.Identification and characterization of the intercellular adhesion molecule-2 gene as a novel p53 target.rClca2 is associated with epidermal differentiation and is strongly downregulated by ultraviolet radiation.CLCA4 inhibits bladder cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT pathway.Identification and characterization of a metastatic suppressor BRMS1L as a target gene of p53.Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.CLCA2 is a positive regulator of store-operated calcium entry and TMEM16A.Machine Learning With K-Means Dimensional Reduction for Predicting Survival Outcomes in Patients With Breast Cancer
P2860
Q28078185-0DB459EF-5894-4CF3-8310-99D57F7226C5Q30978083-623CFB23-F834-4D22-925E-DBC285BD7521Q34762754-5251523F-F8E6-4946-A14F-C9B98BC2646FQ35179521-34A31369-FAC5-4DBF-A437-94638CDA472CQ35191597-C719C981-CE4D-452C-9968-D61A098054D0Q35941297-5DBA507F-6BC2-4287-97ED-5F4E3D198C50Q36100349-273B8698-C4CA-4C6C-9C8C-E0DCD5E51FEBQ36159875-65CF9431-B90A-468E-9FB8-CBFC4701CC0FQ38884723-5102A101-653F-48C2-AE15-773CE945E23EQ39093841-D05C1708-37D4-49AE-929D-5414B21C178AQ41854551-C317962D-3B5A-4CF1-BFB1-D9321A8B6D3AQ42456899-4B502D90-EC78-4623-9964-1646D0850A4BQ47103599-3A8071A7-E8C7-43C7-9E9E-D18FE4CD5416Q47129006-BCEEE3FD-1817-4109-B4D9-5531DEB757FFQ49795695-C933999C-18D1-471E-A98D-2DD1653275E6Q55057433-42C686EB-A773-4A7F-9A49-AE10177BD289Q59129055-3EB13CDE-9F01-4BD7-961E-BC87B94FD42B
P2860
CLCA2, a target of the p53 family, negatively regulates cancer cell migration and invasion.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
CLCA2, a target of the p53 fam ...... r cell migration and invasion.
@ast
CLCA2, a target of the p53 fam ...... r cell migration and invasion.
@en
type
label
CLCA2, a target of the p53 fam ...... r cell migration and invasion.
@ast
CLCA2, a target of the p53 fam ...... r cell migration and invasion.
@en
prefLabel
CLCA2, a target of the p53 fam ...... r cell migration and invasion.
@ast
CLCA2, a target of the p53 fam ...... r cell migration and invasion.
@en
P2093
P2860
P356
P1476
CLCA2, a target of the p53 fam ...... r cell migration and invasion.
@en
P2093
Hiromu Suzuki
Jun Sugisaka
Masashi Idogawa
Miyuki Tamura
Reo Maruyama
Ryota Koyama
Takashi Tokino
Takehiro Hirano
Yasuhisa Shinomura
Yasushi Sasaki
P2860
P304
P356
10.4161/CBT.22280
P577
2012-09-18T00:00:00Z